STAGE IIB LUNG NON-SMALL CELL CARCINOMA AJCC V7

Clinical trials for STAGE IIB LUNG NON-SMALL CELL CARCINOMA AJCC V7 explained in plain language.

Never miss a new study

Get alerted when new STAGE IIB LUNG NON-SMALL CELL CARCINOMA AJCC V7 trials appear

Sign up with your email to follow new studies for STAGE IIB LUNG NON-SMALL CELL CARCINOMA AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Major trial tests daily pill to stop lung Cancer's return

Disease control Ongoing

This large study is testing whether taking a daily pill called erlotinib for two years after lung cancer surgery helps patients live longer. It compares the pill to just regular check-ups (observation) in patients whose cancer has a specific genetic change (EGFR mutation). The go…

Matched conditions: STAGE IIB LUNG NON-SMALL CELL CARCINOMA AJCC V7

Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 01, 2026 14:43 UTC

STAGE IIB LUNG NON-SMALL CELL CARCINOMA AJCC V7

Get alerted when new STAGE IIB LUNG NON-SMALL CELL CARCINOMA AJCC V7 trials appear

Major trial tests daily pill to stop lung Cancer's return